These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19130511)

  • 1. Prospects of metal complexes peripherally substituted with sugars in biomedicinal applications.
    Gottschaldt M; Schubert US
    Chemistry; 2009; 15(7):1548-57. PubMed ID: 19130511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of targeting ligands in medicinal inorganic chemistry.
    Storr T; Thompson KH; Orvig C
    Chem Soc Rev; 2006 Jun; 35(6):534-44. PubMed ID: 16729147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal complexes of maltol and close analogues in medicinal inorganic chemistry.
    Thompson KH; Barta CA; Orvig C
    Chem Soc Rev; 2006 Jun; 35(6):545-56. PubMed ID: 16729148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
    Hermann P; Kotek J; Kubícek V; Lukes I
    Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ParaCEST MRI contrast agents capable of derivatization via"click" chemistry.
    Milne M; Chicas K; Li A; Bartha R; Hudson RH
    Org Biomol Chem; 2012 Jan; 10(2):287-92. PubMed ID: 22069041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons.
    Terreno E; Cabella C; Carrera C; Delli Castelli D; Mazzon R; Rollet S; Stancanello J; Visigalli M; Aime S
    Angew Chem Int Ed Engl; 2007; 46(6):966-8. PubMed ID: 17167807
    [No Abstract]   [Full Text] [Related]  

  • 7. Equilibrium and kinetic properties of the lanthanoids(III) and various divalent metal complexes of the heptadentate ligand AAZTA.
    Baranyai Z; Uggeri F; Giovenzana GB; Bényei A; Brücher E; Aime S
    Chemistry; 2009; 15(7):1696-705. PubMed ID: 19130509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanthanides in magnetic resonance imaging.
    Bottrill M; Kwok L; Long NJ
    Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunable imaging of cells labeled with MRI-PARACEST agents.
    Aime S; Carrera C; Delli Castelli D; Geninatti Crich S; Terreno E
    Angew Chem Int Ed Engl; 2005 Mar; 44(12):1813-5. PubMed ID: 15723362
    [No Abstract]   [Full Text] [Related]  

  • 10. The therapeutic application of lanthanides.
    Fricker SP
    Chem Soc Rev; 2006 Jun; 35(6):524-33. PubMed ID: 16729146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of lanthanides and their complexes with proteins. Conclusions regarding magnetic resonance imaging.
    Aime S; Barge A; Botta M; Terreno E
    Met Ions Biol Syst; 2003; 40():643-82. PubMed ID: 12723161
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging.
    Debroye E; Parac-Vogt TN
    Chem Soc Rev; 2014 Dec; 43(23):8178-92. PubMed ID: 25211043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: lanthanide compounds for therapeutic and diagnostic applications.
    Thompson KH; Orvig C
    Chem Soc Rev; 2006 Jun; 35(6):499. PubMed ID: 16729143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and spectroscopic studies on azo-dye derivatives of polymetallic lanthanide complexes: using diazotization to link metal complexes together.
    Placidi MP; Villaraza AJ; Natrajan LS; Sykes D; Kenwright AM; Faulkner S
    J Am Chem Soc; 2009 Jul; 131(29):9916-7. PubMed ID: 19580269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triethylenetetramine penta- and hexa-acetamide ligands and their ytterbium complexes as paraCEST contrast agents for MRI.
    Burdinski D; Lub J; Pikkemaat JA; Moreno Jalón D; Martial S; Del Pozo Ochoa C
    Dalton Trans; 2008 Aug; (31):4138-51. PubMed ID: 18688432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ; Datta A; Jocher CJ; Raymond KN
    Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards aqueous chiral heptadentate lanthanide complexes as selective shift and relaxation agents for MRS.
    Dickins RS; Badari A
    Dalton Trans; 2007 Sep; (33):3661-8. PubMed ID: 17700829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pH-reporter MRI contrast agents.
    Aime S; Delli Castelli D; Terreno E
    Angew Chem Int Ed Engl; 2002 Nov; 41(22):4334-6. PubMed ID: 12434381
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbohydrate-metal complexes and their potential as anticancer agents.
    Hartinger CG; Nazarov AA; Ashraf SM; Dyson PJ; Keppler BK
    Curr Med Chem; 2008; 15(25):2574-91. PubMed ID: 18855680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.